Home › Multiple Sclerosis › NCT07415824
Multiple Sclerosis Implementation Network (Registry)
Multiple Sclerosis Implementation Network
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * diagnosed with Multiple Sclerosis * can speak and understand English comfortably
About the study
The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality of life through the development and support of implementation research and clinical practice collaboration. MSIN brings together healthcare teams, people with MS, and research leaders in MS and implementation science (IS) to learn, share, test, implement, and disseminate innovations that improve MS care, patient health, and quality of life.
This ClinicalTrials.gov record pertains to the MSIN Patient Registry, which is a comprehensive database that integrates participants' electronic health records from various providers.
Sponsor: The University of Texas Health Science Center, Houston · Participants: 2,000 · Started: Apr 28, 2025
Contact the study team
- Amanda Montague, EdM · Phone: 800-532-7667
Official record on ClinicalTrials.gov — NCT07415824
Locations in the U.S.
| New Jersey | Multiple Sclerosis Association of America, Cherry Hill |
| Texas | The University of Texas at Austin, Austin The University of Texas Health Science Center at Houston (UTHealth Houston), Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.